Back to News
Market Impact: 0.1
Eloxx Pharmaceuticals Appoints Geno J. Germano to Board on October 19, 2026 and Announces Clinical Update
Source: Nasdaq
Management & Governance
On October 19, 2026, Eloxx Pharmaceuticals’ board expanded from five to six directors and appointed Geno J. Germano to the newly created seat. His term expires at the company’s next annual meeting of stockholders.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- Ready for a French test?: Five questions for the ECB
- Meta stock sinks 6% as AI spend pushes free cash flow negative
- Palmer Luckey teams with dire wolf billionaire Ben Lamm to launch $200 million Warhound, unleashing genetically engineered clone dogs of war
- The biggest hurdle to a SpaceX merger with Tesla isn’t Elon Musk. It’s Tesla’s shareholders
- Meta’s deal to keep Zuckerberg in California adds fuel to wealth tax debate ahead of election
- Mark Zuckerberg Plots Deal to Pay Wealth Tax, Keep Meta Control